Literature DB >> 31031193

How to incorporate geriatric assessment in clinical decision-making for older patients with cancer. An implementation study.

Suzanne Festen1, Maaike Kok2, Jana S Hopstaken3, Hanneke van der Wal-Huisman3, Annya van der Leest4, Anna K L Reyners2, Geertruida H de Bock5, Pauline de Graeff6, Barbara L van Leeuwen3.   

Abstract

INTRODUCTION: With the accumulating evidence on the added value on prediction of outcomes of geriatric assessment (GA) in older patients with cancer, the question shifts from whether performing a GA is useful, to how to implement this into standard practice in a feasible and effective way. The effect of implementing GA, and assessment of patient preferences on treatment recommendations by an onco-geriatric multidisciplinary team (MDT), was compared to the recommendation previously made by the tumor board (care as usual).
METHODS: Patients aged 70 years and older with a solid malignancy who were referred to a tertiary care center for diagnosis and treatment recommendations, as provided by a tumor board, were included. The intervention consisted of: a nurse-led GA and assessment of patient preferences prior to the start of oncological treatment, discussing this in an onco-geriatric MDT, and weighing all this information in a structured, stepwise manner. Treatment recommendations formulated by this onco-geriatric MDT were compared to the treatment recommendations by the tumor board.
RESULTS: Of 236 eligible patients, 197 were included. For 27%, treatment recommendations from the onco-geriatric MDT differed from the recommendations formulated by the tumor board. These modifications were mostly towards less intensive curative or palliative treatment. Thirteen percent of patients were subsequently referred to a geriatrician in order to reach a treatment recommendation. DISCUSSION: Implementing an onco-geriatric care trajectory, using GA and assessment of patient preferences, resulted in an adjustment of treatment recommendations for a quarter of patients. Thirteen percent needed subsequent referral to a geriatrician.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical decision-making; Geriatric assessment; Implementation; OPT tool; Older patients with cancer; Patient preferences

Year:  2019        PMID: 31031193     DOI: 10.1016/j.jgo.2019.04.006

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  10 in total

1.  Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices.

Authors:  Grant R Williams; Kathryn E Weaver; Glenn J Lesser; Emily Dressler; Karen M Winkfield; Heather B Neuman; Anne E Kazak; Ruth Carlos; Lucy J Gansauer; Charles S Kamen; Joseph M Unger; Supriya G Mohile; Heidi D Klepin
Journal:  Oncologist       Date:  2020-08-31

Review 2.  Older adults with cancer and their caregivers - current landscape and future directions for clinical care.

Authors:  Sindhuja Kadambi; Kah Poh Loh; Richard Dunne; Allison Magnuson; Ronald Maggiore; Jason Zittel; Marie Flannery; Julia Inglis; Nikesha Gilmore; Mostafa Mohamed; Erika Ramsdale; Supriya Mohile
Journal:  Nat Rev Clin Oncol       Date:  2020-09-02       Impact factor: 66.675

3.  How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology.

Authors:  William Dale; Grant R Williams; Amy R MacKenzie; Enrique Soto-Perez-de-Celis; Ronald J Maggiore; Janette K Merrill; Sweatha Katta; Kimberly T Smith; Heidi D Klepin
Journal:  JCO Oncol Pract       Date:  2020-10-15

4.  Reorganizing the Multidisciplinary Team Meetings in a Tertiary Centre for Gastro-Intestinal Oncology Adds Value to the Internal and Regional Care Pathways. A Mixed Method Evaluation.

Authors:  Lidia S van Huizen; Pieter U Dijkstra; Patrick H J Hemmer; Boudewijn van Etten; Carlijn I Buis; Linde Olsder; Frederike G I van Vilsteren; Kees C T B Ahaus; Jan L N Roodenburg
Journal:  Int J Integr Care       Date:  2021-02-25       Impact factor: 5.120

5.  Perspectives and experiences of patients and healthcare professionals with geriatric assessment in chronic kidney disease: a qualitative study.

Authors:  Carlijn G N Voorend; Noeleen C Berkhout-Byrne; Yvette Meuleman; Simon P Mooijaart; Willem Jan W Bos; Marjolijn van Buren
Journal:  BMC Nephrol       Date:  2021-01-06       Impact factor: 2.388

Review 6.  Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient-A Systematic Review.

Authors:  Petronella A L Nelleke Seghers; Anke Wiersma; Suzanne Festen; Mariken E Stegmann; Pierre Soubeyran; Siri Rostoft; Shane O'Hanlon; Johanneke E A Portielje; Marije E Hamaker
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

7.  Involvement of adult children in treatment decision-making for older patients with cancer - a qualitative study of perceptions and experiences of oncology surgeons and nurses.

Authors:  Bea L Dijkman; Wolter Paans; Hanneke Van der Wal-Huisman; Barbara L van Leeuwen; Marie Louise Luttik
Journal:  Support Care Cancer       Date:  2022-09-01       Impact factor: 3.359

8.  The missing voice in multidisciplinary tumor boards.

Authors:  Gabrielle Rocque; Stephanie Wheeler; Grant R Williams
Journal:  J Geriatr Oncol       Date:  2021-03-12       Impact factor: 3.599

9.  Design of a consensus-based geriatric assessment tailored for older chronic kidney disease patients: results of a pragmatic approach.

Authors:  Carlijn G N Voorend; Hanneke Joosten; Noeleen C Berkhout-Byrne; Adry Diepenbroek; Casper F M Franssen; Willem Jan W Bos; Marjolijn Van Buren; Simon P Mooijaart
Journal:  Eur Geriatr Med       Date:  2021-04-19       Impact factor: 1.710

10.  Impact of Delay on Hospitalization in Older Patients With Head and Neck Cancer: A Multicenter Study.

Authors:  Rosanne C Schoonbeek; Suzanne Festen; Roza Rashid; Boukje A C van Dijk; György B Halmos; Lilly-Ann van der Velden
Journal:  Otolaryngol Head Neck Surg       Date:  2022-01-19       Impact factor: 5.591

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.